This statistic shows the sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group. In 2016, the BPH medication sales for patients aged between 70 and 79 years amounted to over ** billion South Korean won.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
KHIDI. (February 6, 2018). Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 01, 2026, from /statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. "Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won)." Chart. February 6, 2018. ÌÇÐÄÆƽâ°æ. Accessed August 01, 2026. /statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. (2018). Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 01, 2026. /statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. "Sales Value of Outpatient Prescription Drugs for Benign Prostatic Hyperplasia (Bph) in South Korea in 2016, by Age Group (in Billion South Korean Won)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 6 Feb 2018, /statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI, Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) ÌÇÐÄÆƽâ°æ, /statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/ (last visited August 01, 2026)
Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) [Graph], KHIDI, February 6, 2018. [Online]. Available: /statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
